General MedicationsINTRAVENOUSStandard

LEVOTHYROXINE SODIUM

Standard Dose

200MCG/5ML (40MCG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 210632 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength SOLUTION;INTRAVENOUS - 200MCG/5ML (40MCG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2019-04-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 210632 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength SOLUTION;INTRAVENOUS - 200MCG/5ML (40MCG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2019-04-11 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.